Chemistry, Manufacturing, and Controls (CMC)

Chemistry, Manufacturing, and Controls (CMC) refers to the comprehensive set of documentation and scientific information describing how a pharmaceutical product is developed, manufactured, tested, and controlled to ensure consistent quality. CMC covers raw materials, manufacturing processes, facility controls, analytical methods, specifications, stability programmes, and packaging systems. It forms a critical part of regulatory submissions for investigational and marketing applications, demonstrating that a product can be reliably produced at required quality standards.

The biopharmaceutical industry treats CMC as a major development pillar alongside clinical and nonclinical work, particularly for complex biologics where manufacturing defines product performance. CMC challenges include scaling up processes while maintaining product comparability, controlling process variability, and establishing robust analytical methods to monitor critical quality attributes. For advanced therapies, CMC complexity increases due to living cell products, patient-specific manufacturing, and limited batch sizes. Regulatory agencies scrutinise CMC packages to ensure manufacturing readiness, supply reliability, and patient safety. As development timelines compress and global submissions become more common, companies invest heavily in early CMC planning, risk management, and platform manufacturing strategies enabling efficient progression from clinical development to commercial supply.